AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of $402.08 billion. The enterprise value is $465.26 billion.
Important Dates
The last earnings date was Wednesday, February 4, 2026, before market open.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Jan 16, 2026 |
Share Statistics
AbbVie has 1.77 billion shares outstanding.
| Current Share Class | 1.77B |
| Shares Outstanding | 1.77B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 74.53% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 96.40 and the forward PE ratio is 15.62. AbbVie's PEG ratio is 0.89.
| PE Ratio | 96.40 |
| Forward PE | 15.62 |
| PS Ratio | 6.60 |
| Forward PS | 5.94 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.89 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 110.09 |
| EV / Sales | 7.61 |
| EV / EBITDA | 15.82 |
| EV / EBIT | 21.93 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.34 |
| Debt / FCF | n/a |
| Interest Coverage | 8.08 |
Financial Efficiency
Return on equity (ROE) is 1,106.67% and return on invested capital (ROIC) is 22.47%.
| Return on Equity (ROE) | 1,106.67% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 22.47% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.56% |
| Revenue Per Employee | $1.11M |
| Profits Per Employee | $76,836 |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AbbVie has paid $2.36 billion in taxes.
| Income Tax | 2.36B |
| Effective Tax Rate | 35.83% |
Stock Price Statistics
The stock price has increased by +18.60% in the last 52 weeks. The beta is 0.33, so AbbVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +18.60% |
| 50-Day Moving Average | 223.66 |
| 200-Day Moving Average | 210.44 |
| Relative Strength Index (RSI) | 56.92 |
| Average Volume (20 Days) | 7,426,803 |
Short Selling Information
The latest short interest is 19.68 million, so 1.11% of the outstanding shares have been sold short.
| Short Interest | 19.68M |
| Short Previous Month | 19.71M |
| Short % of Shares Out | 1.11% |
| Short % of Float | 1.12% |
| Short Ratio (days to cover) | 2.86 |
Income Statement
In the last 12 months, AbbVie had revenue of $61.16 billion and earned $4.23 billion in profits. Earnings per share was $2.36.
| Revenue | 61.16B |
| Gross Profit | 43.82B |
| Operating Income | 21.21B |
| Pretax Income | 6.60B |
| Net Income | 4.23B |
| EBITDA | 29.42B |
| EBIT | 21.21B |
| Earnings Per Share (EPS) | $2.36 |
Full Income StatementBalance Sheet
The company has $5.67 billion in cash and $68.85 billion in debt, with a net cash position of -$63.18 billion or -$35.75 per share.
| Cash & Cash Equivalents | 5.67B |
| Total Debt | 68.85B |
| Net Cash | -63.18B |
| Net Cash Per Share | -$35.75 |
| Equity (Book Value) | -2.60B |
| Book Value Per Share | -1.49 |
| Working Capital | n/a |
Full Balance SheetMargins
Gross margin is 71.64%, with operating and profit margins of 34.69% and 6.91%.
| Gross Margin | 71.64% |
| Operating Margin | 34.69% |
| Pretax Margin | 10.79% |
| Profit Margin | 6.91% |
| EBITDA Margin | 48.10% |
| EBIT Margin | 34.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $6.92, which amounts to a dividend yield of 3.04%.
| Dividend Per Share | $6.92 |
| Dividend Yield | 3.04% |
| Dividend Growth (YoY) | 5.72% |
| Years of Dividend Growth | 54 |
| Payout Ratio | 281.78% |
| Buyback Yield | -0.23% |
| Shareholder Yield | 2.82% |
| Earnings Yield | 1.05% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for AbbVie is $243.88, which is 7.20% higher than the current price. The consensus rating is "Buy".
| Price Target | $243.88 |
| Price Target Difference | 7.20% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 6.69% |
| EPS Growth Forecast (5Y) | 53.19% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
